Identifying the most appropriate antiretroviral regimen for pregnant women with Human Immunodeficiency Virus (HIV-1) infection can be challenging, mainly due to pregnancy-related physiological alterations which can significantly reduce maternal drug plasma concentration. We would like to report our experience as it consists of an unusual case of low plasmatic concentration of antiretroviral drugs despite regimen intensification in a HIV-positive pregnant woman. It also underlines the need for accurate monitoring and treatment adjustment in pregnant women with Human Immunodeficiency Virus (HIV).
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report
Chiesi, Sheila;Rizzardo, Sebastiano;Piacentini, Daniela;BE, GIORGIA;Lattuada, Emanuela;Tacconelli, Evelina;Lanzafame, Massimiliano
2019-01-01
Abstract
Identifying the most appropriate antiretroviral regimen for pregnant women with Human Immunodeficiency Virus (HIV-1) infection can be challenging, mainly due to pregnancy-related physiological alterations which can significantly reduce maternal drug plasma concentration. We would like to report our experience as it consists of an unusual case of low plasmatic concentration of antiretroviral drugs despite regimen intensification in a HIV-positive pregnant woman. It also underlines the need for accurate monitoring and treatment adjustment in pregnant women with Human Immunodeficiency Virus (HIV).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Altro materiale allegato
Licenza:
Creative commons
Dimensione
523.64 kB
Formato
Adobe PDF
|
523.64 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
